Kross J, Henner W D, Haseltine W A, Rodriguez L, Levin M D, Hecht S M
Biochemistry. 1982 Jul 20;21(15):3711-21. doi: 10.1021/bi00258a029.
The role of the bithiazole moiety of bleomycin in the interaction of the antibiotic with DNA has been studied by the use of synthetic bithiazole derivatives. The DNA affinity of individual C-terminal (bithiazole) analogues of bleomycin was measured in terms of the ability of these species to block the binding of bleomycin to DNA, as judged by diminution of the DNA degradation that attends bleomycin binding. DNA degradation was monitored both by release of [3H]thymine from radiolabeled PM-2 DNA and by alteration of bleomycin-treated DNA oligomers of defined sequence derived from Escherichia coli plasmid pLJ3. It was found that the affinity of the bithiazole derivatives for DNA depended on the presence of the bithiazole moiety itself but more importantly on the number and spacing of positively charged groups; 2'-(2-aminoethyl)-2,4'-bithiazole-4-[3-[(4-aminobutyl) amino]propyl]carboxamide (14), having three positively charged groups at neutral pH, was a reasonably effective inhibitor of DNA degradation by bleomycin. Consistent with the importance of the spacing of the positively charged groups, tetrapeptide S (12) was found to be significantly less inhibitory toward DNA degradation by bleomycin than tripeptide S, in spite of their equal number of positively charged groups and the greater structural similarity of the former to bleomycin A2. Bleomycin is known to cleave DNA perferentially at certain sequences. It was shown that the inhibitors employed in this study diminished DNA cleavage proportionately at each cleavage site; no alteration was observed in the specificity of cleavage. A number of the bithiazole analogues employed as inhibitors of bleomycin-mediated DNA degradation were also utilized in fluorescence quenching experiments with calf thymus DNA. Consistent with the belief that these species inhibit bleomycin degradation by competitive binding to the DNA substrate, the best inhibitors exhibited the greatest fluorescence quenching upon admixture of DNA.
通过使用合成的双噻唑衍生物,研究了博来霉素的双噻唑部分在抗生素与DNA相互作用中的作用。根据这些物质阻断博来霉素与DNA结合的能力,测定了博来霉素各个C末端(双噻唑)类似物对DNA的亲和力,这是通过减少伴随博来霉素结合的DNA降解来判断的。通过从放射性标记的PM - 2 DNA中释放[3H]胸腺嘧啶以及通过改变源自大肠杆菌质粒pLJ3的特定序列的博来霉素处理的DNA寡聚物来监测DNA降解。发现双噻唑衍生物对DNA的亲和力取决于双噻唑部分本身的存在,但更重要的是取决于带正电荷基团的数量和间距;2'-(2-氨基乙基)-2,4'-双噻唑-4-[3-[(4-氨基丁基)氨基]丙基]甲酰胺(14)在中性pH下具有三个带正电荷的基团,是博来霉素介导的DNA降解的合理有效抑制剂。与带正电荷基团间距的重要性一致,尽管四肽S(12)和三肽S带正电荷基团的数量相等且前者与博来霉素A2的结构相似性更高,但发现四肽S对博来霉素介导的DNA降解的抑制作用明显小于三肽S。已知博来霉素在某些序列处优先切割DNA。结果表明,本研究中使用的抑制剂在每个切割位点按比例减少DNA切割;未观察到切割特异性的改变。一些用作博来霉素介导的DNA降解抑制剂的双噻唑类似物也用于小牛胸腺DNA的荧光猝灭实验。与这些物质通过与DNA底物竞争性结合来抑制博来霉素降解的观点一致,最佳抑制剂在与DNA混合时表现出最大的荧光猝灭。